Castro et al. v. Sanofi Pasteur, Inc., No. 11-cv-07178 (D. N. J.)

Faruqi & Faruqi represents a proposed class of pediatricians and pediatric practice groups challenging Sanofi-Pasteur, Inc.’s illegal maintenance of a monopoly on the children’s vaccine Menactra in violation of  § 2 of the Sherman Act.  Plaintiffs allege a scheme where Sanofi-Pasteur employs a series of anticompetitive and exclusionary bundling and tying contracts with multiple physician buying groups across the United States to preserve their monopoly on Menactra.  As a result of Sanofi-Pasteur’s conduct, plaintiffs paid more for Menactra than they would have in a competitive market.